Chemerin down-regulates insulin signalling, induces insulin resistance, inhibits insulin receptor substrate 1 and glycogen synthase kinase phosphorylation, and impairs glucose uptake in skeletal muscle [29,30,31]. The gene discussed is INS; the disease is Insulin resistance.